Despite CRP was excluded from the pathogenesis of inflammatory related conditions (i.e., such as atherosclerosis) by a subsequent mendelian randomization, it remains a proxy of the overall systemic inflammatory status. This evidence concerns the gene CRP and atherosclerosis.